Back to BT Blue Trust, Inc.

VKTXVKTX

Showing 8 of 13 quarters

Position history for BTBlue Trust, Inc.'s holdings in Viking Therapeutics, Inc.

Yes. Blue Trust holds 396 shares of VKTX (Viking Therapeutics), worth $12,910, as of its Q3 2026 13F filing. It reduced the position by 86 shares (-17.8%) from Q2 2026. Blue Trust has held VKTX since Q3 2024, across 9 quarterly 13F filings.

Current Value

$12,910

Current Shares

396

Total Value Change

-$62,942

Total Shares Change

-1,489

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
396
-17.8%
$12,9100.0%$32.60
0
2026-Q2
Unchanged
482
0.0%
$18,8030.0%$39.01
0
2026-Q1
Decreased
482
-40.6%
$15,6850.0%$32.54
0
2025-Q4
Decreased
812
-38.6%
$28,5670.0%$35.18
0
2025-Q3
Decreased
1,323
-46.6%
$34,7690.0%$26.28
0
2025-Q2
Increased
2,476
+27.2%
$65,6150.0%$26.50
26
2025-Q1
Increased
1,947
+3.3%
$47,0200.0%$24.15
21
2024-Q4
Increased
1,885
+363.1%
$75,8520.0%$40.24
34

Optional analytics helps us improve. How it’s used